MedPath

Effects of vitamin C on covid-19 patients

Phase 3
Conditions
Covid-19.
COVID-19
virus identified
U07.1
Registration Number
IRCT20220228054146N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Adults (age 18 years or older)
SPO2<92%
Being treated in the ward
Positive PCR test
Involvement of Chest-CT-Scan

Exclusion Criteria

Patients with a history of allergy to vitamin C
Patients with dyspnea caused by cardiogenic pulmonary edema
Pregnant women
Lactating women
Patients with a previous history of end-stage pulmonary disease, end-stage malignant tumor, diabetic ketoacidosis, severe kidney
Active kidney stone disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath